ON THIS PAGE: You will find out more about the late effects of treatment, which are side effects that can occur long after treatment for non-Hodgkin lymphoma (NHL) has ended. Use the menu to see other pages.
Vea la serie de videos "Salir adelante" (Moving Forward) en inglés, adaptados de este contenido.
El tratamiento contra el cáncer ha sido una parte importante de su vida durante algún tiempo. Ahora que el tratamiento ha finalizado, su rutina, emociones y prioridades cambiarán de nuevo a medida que usted se ajuste a la vida después del tratamiento.
There are more than 18 million cancer survivors living in the United States, over 500,000 of which are survivors of childhood cancer.
In the last 30 years, cancer treatment and supportive care have improved significantly. As a result, more than 80% of children treated for cancer live 5 years or more after treatment. At the same time, because cancer treatments are powerful, these survivors are at risk for side effects that can occur over the long term, called "late effects," that are related to their prior cancer treatment.
Watch the "Moving Forward" video series for young adults, adapted from this content.
Cancer treatment has been a major part of your life for some time. Now that treatment is over, your routines, emotions, and priorities will change again as you adjust to life after treatment.
ON THIS PAGE: You will read about your child’s medical care after treatment is finished and why this follow-up care is important. Use the menu to see other pages.
Care for children diagnosed with desmoplastic infantile ganglioglioma (DIG) does not end when active treatment has finished. Your child’s health care team will continue to check that the tumor has not come back, manage any side effects, and monitor your child’s overall health. This is called follow-up care. All children treated for a tumor, including DIG, should have life-long follow-up care.
ON THIS PAGE: You will read about your child’s medical care after treatment is finished and why this follow-up care is important. Use the menu to see other pages.
Care for children diagnosed with medulloblastoma does not end when active treatment has finished. Your child’s health care team will continue to check that the tumor has not come back, manage any side effects, and monitor your child’s overall health. This is called follow-up care. All children treated for medulloblastoma should have life-long, follow-up care.
ON THIS PAGE: You will read about your child’s medical care after treatment is finished and why this follow-up care is important. Use the menu to see other pages.
Care for children diagnosed with a central nervous system (CNS) tumor does not end when active treatment has finished. Your child’s health care team will continue to check that the tumor has not come back, manage any side effects, and monitor your child’s overall health. This is called follow-up care. All children treated for a CNS tumor should have life-long, follow-up care.
ON THIS PAGE: You will read about your medical care after treatment for a neuroendocrine tumor of the gastrointestinal tract (GI tract NET) is completed and why this follow-up care is important. Use the menu to see other pages.
Care for people diagnosed with a GI tract NET does not end when active treatment has finished. Your health care team will continue to check that the tumor has not come back, manage any side effects, and monitor your overall health. This is called follow-up care.
